FDA Suggests Endpoints for Medicine-Assisted Opioid Treatments

Drug sponsors may not have to prove that a proposed medicine-assisted therapy helps addicts completely kick opioids but they will have to detail how well it helps cut dependence to win FDA approval, the agency says in a new draft guidance.
Source: International Pharmaceutical Regulatory Monitor